<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 38 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page37.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=38">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 38 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 38</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=38"><img src="../thumb/38.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>Central Nervous System - 1.2.3 / 1.3 / 1.3.1                                     2020-04 / 7
       drug abuse, chron.pulm.insuffic., elderly/debilit., musc.weakn., imp.   Dosage: Init.low.recomm.dos. Do not exceed max. dos. Treatm.pe-  816787-018: 1 mg, 30, R109,04
       liv./kidn.funct., sev.hepat.insuffic., organ. brain changes esp.arterio-  riod: few days – 2 wks.  816787-026: 1 mg, 90, R327,13
       scleros., epilepsy, discont. grad., depend., treatm.durat.not to exceed   1 tab.bef.retir. Elderly/hepat., ren.or chron.resp. insuffic: Init.½ tab.,   Dosage: Indiv.& place und.tong., will dissolve.in approx.20 secs. Do
       4 wks. incl.taper.off period  dos.may be incr.to 7,5 mg if necess.  not swallow for at least 2 min.aft.admin. Treatm.durat.not to exceed
       Drug interactions: Depress.eff.of CNS depress. enhanc., erythro-  Contra-indications: Myasthen.grav., resp.fail., sev. sleep apnoea,   8-12 wks.incl.tapering. Elderly & debilitat: Init.dly. dos. not to ex-
       myc.incr.absorpt.prolong.eliminat.  hepat.insuffic., childr. und.18 yrs., pregn.& lactat.  ceed 2 mg. If ren./hepat.funct.imp/. resp. insuffic.sev. low & reduc.
                                     Side-effects: Bitter aft.taste, dizzin., headache, resid.somnol., dys-  dos.freq.adjust.accord.to pt.respons.with freq.monit.
       ZOLNOXS, (AspenPharmacare: Pharma) Pharmacare [P/S]  peps., naus., dry mouth, allerg./ cutan.reacts., anterograde amnes.,   Premed: Recomm.adult dos: 2 mg the night bef. proced.and/or
       Zolpidem tartrate.            psych. reacts., rebound eff.  1-2 hrs.bef.proced. If heighten. sedat. eff.desir.0,05 mg/kg to max.
       Indications: Short-term insomn.treatm.when sev./ disabl./ex-  Special precautions: Treatm.durat.not to exceed 4 wks.incl.taper.  of 4 mg may be used. In case of loc.anaesthes.& diagnost.proced.
       trem.stressful.               off period, re-eval.pt. status bef.max.treatm.per.extend., grad.withdr.,   requir. pt.co-op., concom.analges.recomm.
       (S5) TABS. 36/2.2/0328        poss. depend., loss.of effic with rep.use,not recomm. for prim.treatm.  Ac.anx.states: Recomm.dos: 4 mg.
       703986-001: 10 mg, 30, R122,79  of psychot.illn., not to be used alone to treat depress./anx.with de-  (S5) INJ, [P/S] JX/2.6/295. 4 mg/ml.
       Dosage: Treatm.max.4 wks.incl.taper.off period.  press., alcoh.& drug abuse hist.,  Indications: Premed., ac.anx., status epileptic. caus.by var.part.&
       10 mg immed.bef.bedt. Elderly, debilitat.& in hepat. insuffic:   Drug interactions: Depress.eff.of CNS depress. enhanc., erythro-  gen.seiz.types.
       5 mg at bedt.                 mycin poss.enhanc.eff.       782394-027: 5x1 ml amps, R397,49
       Contraindications: Myasthen.grav., sleep apnoea, ac.& sev.pulm.  Dosage: Indiv.to low.effect.dos.& short.poss time. Admin.either IV/
       insuffic., sev.hepat. insuffic., childr.und.18 yrs., safety in pregn.not   ZOPIVANE, Cipla Medpro [P/S]  IM but IV route prefer. Not for long term/chron.treatm.
       est., breast feed., prim.treatm.of depress.syndr./ psychot. illn., al-  Zopiclone.  Premed: IV admin: 0,05 mg/kg 30-45 mins.pre-op. IM admin:
       coh/drug abuse hist.          Indications: Short-term treatm.of insomn.in adults.  0,05 mg/kg 2 hrs pre-op.
       Side effects: Centr.&periph.nerv.syst.effs., libido chang., GI disturbs.,   (S5) TABS. 35/2.2/0021  Ac.anx: Init: 0,025-0,03 mg/kg. Repeat 6 hrly. Transf. to oral treatm.
       vis.disturbs., psychiatr. & paradoxic.reacts. esp.in childr.& elderly, hy-  700722-003: 7,5 mg, 30, R52,43  once ac.sympt.control.
       potens., allerg.reacts.incl.anaphylax., anterograde amnes., depend.&   Dosage: 1 tab.bef.retir.not exceed.dos. Elderly, imp. liv.funct./chron.   Status epileptic: 18 yrs & older: Init. 4 mg slow IVI (2 mg/min)
       toler., unmask.of pre-exist.depress.  resp. insuffic: ½ tab advis. init., dos.may be incr.to 7,5 mg if necess.   if reqd.an addit.4 mg IV may be admin. after 10-14 min.observat.
       Special precautions: Re-eval.pt.status bef.max. treatm.per.ex-  Ren. insuffic: Init.with ½ tab.  Max.8 mg/12 hrs. If seiz.control not observ.10-15 min.aft.2  dos.
                                                                                            nd
       tend., floppy inft.syndr.in neonates if admin.dur.late pregn./labour,   Contraindications: Myasthen.grav., resp.fail., sev.hepat.insuffic.,   employ other meas.to control status epileptic.
       poss.physic.depend. & withdr.sympts.in neonates born to mothers   sev.sleep apnoea syndr., safety in pregn.not est., lactat., childr.und.18   Contraindications: CNS depress., coma, sleep apnoea, resp.insuf-
       chron. treatm.dur.late pregn., ensure 7-8 hrs. uninterrupt. sleep to   yrs., pre-exist. CNS depress.or coma.  fic., childr.und.12 yrs. , safety in pregn.not est., Inj.also: myasth.grav.,
       reduc.risk of anterogr. amnes., rebound insomn.on withdr.therefore   Side effects: Bitter aft.taste, rebound eff., headache, vis.disturbs.,   sev.hepat. insuffic, Subling.tabs:
       withdr. grad., depend.risk great.with psych. disords. /alcoh.& drug   dysarthr., CNS effs.incl. anterogr.amnes., paradoxic.excitat., libido   Side effects: Drowsin., sedat., dizzin., lethargy, atax., vertigo, ex-
       abuse hist., chron.resp. insuffic., depress., suicid.tendenc., cont.lact  chang., urin.effs., GI disturbs., bld.disords., jaund., hypersens. re-  trapyramid.sympts., trem., slurr. speech, headache, convuls., amnes.,
       Drug interactions: Enhanc.sedat.eff.with other CNS depress.&   acts., resp.depress., hypotens., withdr. sympt.with abrupt. discont.   coma, GI disturbs., psych.disords., paradox.reacts., withdr. sympts.
       alcoh., cmpds.inhibit.hepat. enzymes partic. cytochrome P450 may   Special precautions: Grad.discont., depend., alcoh. & drug abuse   follow.abrupt discont., narr.angle glauc., musc.weakn., asthen., un-
       enhanc. activ., cmpds.induc.hepat.enzymes partic. cytochrome   hist., may mask sympts.of depress., not appropr.for chron.psychos.  steadin., libido chang., urin.retent./incontin., allerg.skin reacts., alo-
       P450 may reduc. eff.          treatm./ phobic/ obsess.states, personal.disords., organ. brain chang.  pec., bld.dyscras., vis.disturbs., hypotens., hypertens. with inj., hy-
                                     esp.arterioscleros., musc.weakn., impair. liv./kidn. funct., elderly &
       ZOLPIHEXAL 10, Sandoz [P/S]   debilit.pts., loss. of effic with rep.use.  persens.reacts.incl. anaphylact.reacts., SIADH, hyponatraem., resp.
       Zolpidem tartrate.            Drug interactions: Depress.eff.of CNS depress. enhanc., poss.en-  depress., apnoea, worsen.of sleep & obstruct.pulm.dis., hypotherm.
       Indications: Short-term insomn.treatm.when sev./ disabl./ex-  hanc.eff.with erythromycin, cisapride enhanc.sedat.eff.  Warnings and special precautions: Psychot. illn./depress.disor-
       treme distress                                             ds., poss.release of suicid. tendenc. in depress.pts.due to disinhibit.
       (S5) TABS. 36/2.2/0095                                     eff., pres. anx. poss.relat.to underly.physic./psychiatr.disord. where
       701980-001: 10 mg, 30, R108,45                             more specif.treatm.avail., not shown to be of signific.benef.with co-
       Dosage: Treatm.max.4 wks.incl.taper.off period.  1.3  Anxiolytics  exist.GI/CV disords., epilept., pulm.dis., limit. pulm.reserve, ac.narr.
       10 mg immed.bef.bedt. Elderly, debilitat.& in hepat. insuffic:   angle glauc., mysthen.grav., imp.kidn./liv.& resp.funct., period.haema-
       5 mg at bedt.                                              tolog.& liv.funct.tests with long term ther., discont.if paradoxic.reacts.
       Contraindications: Myasth.grav., sleep apnoea, ac.& sev.pulm. 1.3.1  Benzodiazepines  pres., where drop in BP may lead to CV or cerebrovasc. complicat.,
       insuffic., sev.hepat.insuffic., childr. und.18 yrs., safety in pregn.not   monit.for upp GI dis sympts. as oesophag.dilatat.report.& only revers-
       est., breast feed., prim.treatm.of psychot.illn., alcoh/drug abuse hist.      (See also 1.2.1)  ible when treatm.withdr.within 2 mnths., pregn., depend., alcohol./
       Side effects: CNS effs., musc.weakn., atax., double vis., GI dis-  XANOR (MDR Listing)  drug.abuse hist., signific. personality disords., withdr.sympts.theref.
       turbs., libido chang., skin reacts., anterograde amnes., unmask.  grad. withdr., anx.accomp.by underly. depress.disord., convuls.more
       of pre-exist.depress., psych.& paradoxic.reacts.esp.in childr.& el-  ADCO-ALZAM, (Adco Generics) AI Pharm Ltd [P/S]  common with pre-exist.seiz.disords./ meds.low.convuls. threshold,
       derly, depend.& tol.          Alprazolam.                  crosses placenta & excret.in breast milk, elderly/debilitat., SL Tabs
       Special precautions: Re-eval.pt.status bef. max. treatm. per.ex-  Indications: Anx.disords.& anx.assoc.with depress. (effectiven.  also: Observ.x24 hrs. aft.last dos & when used for short proced.on
       tend., floppy inft.syndr.in neonates if admin. dur.late pregn./labour,   of long-term use exceed. 6 mnths.not est.), panic relat.disords.for   out-pt basis pt.to be accompan.by responsible adult on discharge,
       poss.physic.depend. & withdr.sympts.in neonates born to mothers   up to 8 mnths.  reduc.narcot. &/ analges.dos when used in combinat., not recomm.
       chron. treatm.dur.late pregn., ensure 7-8 hrs. uninterrupt. sleep to   (S5) TABS. 30/2.6/0212,0211, 0213.  for obstet.use. Inj.also: Poss.resp.depress.& CV collapse follow.IV/
       reduc.risk of anterogr. amnes., withdr./rebound phenom.when dis-  821071-009: 0,25 mg, 30, R24,68  IM inj. admin. SL tabs & tabs cont.lact., 2,5 mg tab.cont.tartrazine
       cont., rebound insomn.on withdr.therefore withdr.grad., depend.   821071-017: 0,25 mg, 100, R82,62  Drug interactions: CNS depress.incl.alcoh.& barbit. enhanc.de-
       risk great.with psych.disords/alcoh.& drug abuse hist., chron.resp.  821098-004: 0,5 mg, 30, R34,54  press.eff., incr.plasma conc.with valproate, incr.half-life with probene-
       insuffic., depress., suicid. tendenc.  821098-012: 0,5 mg, 100, R115,23  cid, reduc. sedat. effs.with theophyll.& aminophyll., hepat. enzyme.
       Drug interactions: Enhanc.sedat.eff.with other CNS depress.&   821101-005: 1 mg, 30, R63,95  inhibit.enhanc.activ.
       alcoh., cmpds.inhibit.hepat. enzymes partic.cytochrome P450 may   821101-013: 1 mg, 100, R213,16
       enhanc. activ., cmpds.induc.hepat.enzymes partic. cytochrome   Dosage: Indiv.using principle of low.effect.dos.  AZOR, (Aspen Pharmacare: Pharma) Pharmacare [P/S]
                                                                  Alprazolam.
       P450 may reduc.eff.           Anx: Init. 0,25-0,5 mg 3xdly, usual dos.range: 0,5-4 mg dly.in div.
                                     doses.                       Indications: Anx.disords.& anx.assoc.with depress. (effectiven.of
       ZOPICLONE UNICORN 7,5, (Unicorn) Camox [P/S]  Depress: Init. 0,5 mg 3xdly, usual dos.range: 1,5-4 mg dly.in div.doses.   long-term use exceed. 6 mnths.not est.).
       Zopiclone.                    Geriatr.pts./debilitat.dis: Init.0,25 mg 2-3xdly, usual dos.range: 0,5-  (S5) TABS. 29/2.6/0180, 0181, 0182.
       Indications: Short-term treatm.of insomn.in adults when sev./  0,75 mg dly in div.dos. incr. grad.if need.& tolerat.  823244-008: 0,25 mg, 100, R82,31
       disabl./subj.pt.to extr.stress.  Panic relat.disords: Init. 0,5-1,0 mg at bedt., adjust. to pt.respons.   823252-019: 0,5 mg, 100, R115,62
       (S5) TABS, A39/2.2/0021       Dos.increm.no great. than 1 mg every 3-4 days. Addit.dos.can be   823260-003: 1 mg, 100, R213,17
       707688-001: 7,5 mg, 30, R51,79  added till a 3-4xdly sched.is achiev. Max. 10 mg dly.  Dosage: Indiv.using principle of low.effect.dos.
       Dosage: Use low.recomm.dos.init. Do not exceed max. dos. Durat.  Contraindications: Schizophren., pregn., labour & lactat., childr.  Anx: Init. 0,25-0,5 mg 3xdly, incr.when necess.to total dly.dose of
       of treatm.to be as short as poss. vary. from a few days to 2 wks.  und.18 yrs., psychot.pts.& pts. with depress./ suicid.tendenc.un-  3-4 mg. Geriatr.pts./debilitat: 0,25 mg 2-3xdly.
       with max.incl. taper. off process of 4 wks. Re-eval.pt. if use &gt; 4 wks.  less there is mark. anx.  Panic attacks/depress: Dos.of up to 10 mg dly.
       Adults: 7,5 mg shortly bef.retir.  Side effects: CNS eff., co-ordinat.disords., trem., atax., blurr.vis.,   Contraindications: Porphyr., pre-exist.CNS depress./coma,
       Elderly/imp.hepat.funct./chron.resp.insuffic.: Init. 3,75 mg. If   GI sympts., mass chang., adverse behav.eff., musculoskelet.weakn.,   ac.pulm.insuffic., sleep apnoea, pregn., lactat., chron.psychos., pho-
       necess.may incr.to 7,5 mg.    dyston., fatig., slurr.speech, salivat.& libido chang., menstr. irregul.,   bic/obsess. states.
       Ren.insuffic: Init.3,75 mg    incontin., urin.retent., bld.dyscras., abnorm. liv.funct., jaund., incr.IC   Side effects: CNS eff., vertigo, headache, dysarthria, libido chang.,
       Contraindications: Resp.fail., sev.sleep apnoea syndr., sev.hepat.  press., amnes.& paradox. excitat., dermatit.  tremor, vis.disturbs., salivat.chang., jaund., bld.disords., hypersens. re-
       insuffic., myasth.grav., childr. und. 18 yrs., safety in pregn.& lactat.not   Special precautions: Elderly/debilit.pts., pulm. dis., impair.ren./   acts., resp.depress.& hypotens.with high dos., rebound anx.& insomn.
       est., monother. of depress./anx.with depress.as suicide may precipit.  hepat.funct., hallucinat., withdr. slow.esp. epilept., depend.potent.  Special precautions: Chron.pulm.insuff., abuse potent., elderly/
       Side effects: : Dizzin., headache, resid.somnol., anterograde amnes.,   Drug interactions: CNS depress.-addit.eff., incr. plasma conc.  debilit.pts., imp.ren./ hepat. funct., poss.suic.& aggress.behav.pre-
       nightmares, irritabil., confus., hallucin., aggressiven.& inappropr be-  of imipramine & desipramine, cimetidine or macrolide antibiot.  cipitat., organ.brain chang., inhib.of psycholog.adjustm.in bereavem.,
       hav., drowsin., inco-ordinat., bitt.taste, GI disturbs., prurit.& rash as   may delay clear.  withdr.slow.esp.epilept., depend. potent., provokes seiz., cont.lact.
       hypersens.signs, rebound effs.                             Drug interactions: CNS depress.-addit.eff.
       Special precautions: Alcoh./drug abuse hist., poss. depend./  ATIVAN, (Aspen Pharmacare: Pharma) Pharmacare [P/S]
       abuse, ren./liv./resp.insuffic., elderly, withdr.grad., 7-8 hrs.sleep   Lorazepam.  BETAPAM, Ranbaxy [P/S]
       recomm.to prev.anterograde amnes./ment.confus., not recomm.for   Indications: Anx.disords.or short term relief of anx.sympt./anx.as-  Diazepam.
       prim. treatm.of psychot.illn.  soc.with depress.sympts.    Indications: Anx.in neurot.pts., pre-op., alcoh. withdr.syndr.
       Drug interactions: Depress.effs of CNS depress. & alcoh.enhanc.,   (S5) TABS, [P/S] X/2.6/82, D/2.6/126, 128.  (S5) TABS. L/2.6/185.
       cytochrome P450 enzyme inhibit. incr. effs.& induc.decr.plasma conc.  782408-001: 0,5 mg, 100, R237,41  708062-024: 5 mg, 1 000, R115,64
                                     705500-012: 1 mg, 100, R324,29
                                                                  Dosage: Start with low.recomm.dos.not exceed. max.dos. Durat.
       ZOPIGEN, (Mylan) Xixia [P/S]  705519-015: 2,5 mg, 100, R741,37  of treatm.incl.taper.-off process not to exceed. 4 wks for insom-
       Zopiclone.                    Dosage: Adults: 2-3 mg/day in div.dos. Elderly/ debilit: 1-2 mg   nia/8-12 wks for anxiety. Re-eval.pt.in case of poss.extens.
       Indications: Short-term treatm.of insomn.in adults when sev./  dly in div.dos.  Anxiety: Mild: Usual.2 mg 3xdly. Sev: 15-30 mg dly.in div.dos.
       disabl./subj.pt.to extr.stress.  (S5) SUBLING.TABS, [P/S] R/2.6/319.  Sleep disturbs: 5-10 mg at night.
       (S5) TABS, 36/2.2/0426        Indications: Premed.bef.maj./minor diagnost. proced., sev.ac.anx.  Contraindications: Infts., depress., clos.angle glauc., myasth.grav.,
       705115-001: 7,5 mg, 30, R50,92  episodes.                  treatm.of psychot.pts., not to be used as an antidepress., lactat.</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page37.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page33.html">33</a>&nbsp;&nbsp;&nbsp;<a href="page34.html">34</a>&nbsp;&nbsp;&nbsp;<a href="page35.html">35</a>&nbsp;&nbsp;&nbsp;<a href="page36.html">36</a>&nbsp;&nbsp;&nbsp;<a href="page37.html">37</a>&nbsp;&nbsp;&nbsp;<a href="page38.html">38</a>&nbsp;&nbsp;&nbsp;<a href="page39.html">39</a>&nbsp;&nbsp;&nbsp;<a href="page40.html">40</a>&nbsp;&nbsp;&nbsp;<a href="page41.html">41</a>&nbsp;&nbsp;&nbsp;<a href="page42.html">42</a>&nbsp;&nbsp;&nbsp;<a href="page43.html">43</a>
             </td>
             <td width="35%"><a href="page39.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page39.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
